News Conference News ESC 2025 Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes Todd Neale September 08, 2025
News Conference News ESC 2024 Streamlined European AF Guidelines Emphasize ‘Whole’ Patient Todd Neale September 06, 2024
News Conference News ESC 2024 STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines Todd Neale September 06, 2024
News Conference News ESC 2023 FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF Shelley Wood August 28, 2023
News Conference News ESC 2023 NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm Todd Neale August 25, 2023
News Conference News ESC 2022 ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death Todd Neale September 02, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News ESC 2021 In HFrEF, AI Shows Promise For Predicting Beta Blocker Response Yael L. Maxwell September 03, 2021
News Conference News ESC 2021 LOOP and STROKESTOP: Impact of AF Screening May Hinge on Arrhythmia Burden Todd Neale August 29, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Conference News ESC 2020 Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 Shelley Wood August 29, 2020
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2017 EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib Todd Neale September 05, 2017
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016